68Ga-PSMA Uptake by Dermatofibroma in a Patient with Prostate Cancer

AYDIN F., Akcal A., ÜNAL B., Goksu S., GÜNGÖR F.

Clinical Nuclear Medicine, cilt.42, sa.5, ss.358-360, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1097/rlu.0000000000001591
  • Dergi Adı: Clinical Nuclear Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.358-360
  • Anahtar Kelimeler: Ga-68-PSMA PET/CT, dermatofibroma, PSMA, GA-68-LABELED PSMA LIGAND, HBED-CC, PET/CT, EXPRESSION, CARCINOMA, DIAGNOSIS
  • Akdeniz Üniversitesi Adresli: Evet

Özet

© 2017 Wolters Kluwer Health, Inc. All rights reserved.Prostate-specific membrane antigen (PSMA) is a typ. 2 transmembrane protein that is highly expressed in prostate cancer cells. 68Ga-PSMA PET/CT imaging is a modality used to determine the extent of prostate cancer. Various other neoplasias may also express PSMA, which appears as 68Ga-PSMA uptake in PET/CT imaging. A 71-year-old man with prostate cancer underwent 68Ga-PSMA PET/CT imaging for restaging after having an elevated prostate-specific antigen level. Subcutaneous lesions showing focal PSMA uptake were detected, one of which was excised. The histopathologic diagnosis was dermatofibroma.